Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Kim Koo Museum & Library

15 abr 2026 8:30 a.m. - 16 abr 2026 5:00 p.m.

255, Hyochang-dong (Imjeong-ro 26), Yongsan-gu,, Seoul 140-889, Korea, Republic of

DIA Korea Annual Meeting 2026

S9 - Practical Implementation of Next-Generation Post-Marketing Safety Studies

Session Chair(s)

Min-Jung  Lim, MPHARM, RPH

Min-Jung Lim, MPHARM, RPH

CEO & Senior Pharmacovigilance Consultant, MediSafe, Pharmacovigilance Services, Korea, Republic of

Seongsik  Kang, MD

Seongsik Kang, MD

Senior Vice President, HANDOK, Inc, Korea, Republic of

Speaker(s)

Fuminori  Okubo

Current Status of RWD-Based Safety Studies (Database Studies) in Japanese PMS

Director, Strategic Excellence Dept, RWD Solutions Div., CMIC Co., Ltd., Japan

Hye Young  Kim, MD, PHD

Case Study : RWD-Based Safety Study in RMP – Korea

VP, Head of Medical Affairs, SK bioscience, Korea, Republic of

Seong-jun  Byun, PHD

Practical Implementation of Next-Generation Post-Marketing Safety Studies From RMP Safety Questions to Practical RWD Study Design in Korea

Director, DreamCIS Inc., Korea, Republic of

Seung Hee  Jeong, PHD

Seung Hee Jeong, PHD

RWE Generation Team Lead, , Pfizer Korea, Korea, Republic of

Jung Ae  Kim, PHD

Jung Ae Kim, PHD

Professor, Pharmacogenomics Research Center, Inje University, Korea, Republic of

So Hee  Kim, PHD

So Hee Kim, PHD

Director / Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.